Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceutica
Recalled April 16, 2025 · FDA recall D-0351-2025 · Glenmark Pharmaceuticals Inc., USA
Hazard
CGMP Deviations · FDA Class II
Units
N/A
Sold at
U.S. Nationwide
Description
CGMP Deviations
Product
Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →